Tianru Jin

Tianru Jin

University of Toronto

H-index: 52

North America-Canada

About Tianru Jin

Tianru Jin, With an exceptional h-index of 52 and a recent h-index of 33 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of molecular biology and endocrinology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice

1655-P: GLP-1R Is Required for Resveratrol in Exerting Its Metabolic Beneficial Effect in HFD-Challenged Male Mice

1654-P: Hepatic FGF21 Is Required for Curcumin and Resveratrol to Exert Their Metabolic Beneficial Effect in Male Mice

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1

Tirzepatide, a new class of incretin-based drug for diabetes

Commentary: Can FXR serve as a potential target for COVID-19 prevention?

Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

Comparison of beneficial metabolic effects of liraglutide and Semaglutide in male C57BL/6J mice

Tianru Jin Information

University

Position

___

Citations(all)

8851

Citations(since 2020)

3450

Cited By

6771

hIndex(all)

52

hIndex(since 2020)

33

i10Index(all)

109

i10Index(since 2020)

72

Email

University Profile Page

University of Toronto

Google Scholar

View Google Scholar Profile

Tianru Jin Skills & Research Interests

molecular biology and endocrinology

Top articles of Tianru Jin

Title

Journal

Author(s)

Publication Date

Short‐term semaglutide treatment improves FGF21 responsiveness in primary hepatocytes isolated from high fat diet challenged mice

Physiological Reports

Jia Nuo Feng

Weijuan Shao

Tianru Jin

2023/3

1655-P: GLP-1R Is Required for Resveratrol in Exerting Its Metabolic Beneficial Effect in HFD-Challenged Male Mice

Diabetes

JIA NUO FENG

WEIJUAN SHAO

TIANRU JIN

2023/6/20

1654-P: Hepatic FGF21 Is Required for Curcumin and Resveratrol to Exert Their Metabolic Beneficial Effect in Male Mice

Diabetes

WEIJUAN SHAO

JIA NUO FENG

TIANRU JIN

2023/6/20

Resveratrol intervention attenuates chylomicron secretion via repressing intestinal FXR-induced expression of scavenger receptor SR-B1

Nature communications

Juan Pang

Fitore Raka

Alya Abbas Heirali

Weijuan Shao

Dinghui Liu

...

2023/5/9

Tirzepatide, a new class of incretin-based drug for diabetes

Tianru Jin

2023/5/1

Commentary: Can FXR serve as a potential target for COVID-19 prevention?

Acta Pharmaceutica Sinica. B

Juan Pang

Jia Nuo Feng

Wenhua Ling

Tianru Jin

2023/4

Erratum to: A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

Science China Life Sciences

Zekai Wu

Tianru Jin

Jianping Weng

2023/12

Comparison of beneficial metabolic effects of liraglutide and Semaglutide in male C57BL/6J mice

Canadian Journal of Diabetes

Dinghui Liu

Jianqiu Gu

Weijuan Shao

Juan Pang

Xiaoxian Qian

...

2022/4/1

The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—therapeutic potential exploration in lung injury

Juan Pang

Jia Nuo Feng

Wenhua Ling

Tianru Jin

2022/11/1

Hepatic hormone FGF21 and its analogues in clinical trials

Weijuan Shao

Tianru Jin

2022/3/25

Fibroblast growth factor 21 and dietary interventions: what we know and what we need to know next

Tianru Jin

2022/10/26

Dietary resveratrol intervention improves lipid homeostasis via attenuating HFD-induced fecal chenodeoxycholic acid and jejunum SR-B1 elevation

Juan Pang

Fitore Raka

Alya Abbas Heirali

Weijuan Shao

Dinghui Liu

...

2022/9/27

Liraglutide stimulates the β-catenin signaling cascade in mouse epididymal fat tissue

Journal of Molecular Endocrinology

Jianqiu Gu

Weijuan Shao

Dinghui Liu

Jia Nuo Feng

Juan Pang

...

2022/8/1

Hormones that are involved in metabolic homeostasis: Overview of the past century and future perspectives

Jia Nuo Feng

Tianru Jin

2022/6/1

Current understanding and controversies on the clinical implications of fibroblast growth factor 21

Yasaman Badakhshi

Tianru Jin

2021/7/4

Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment

Juan Pang

Mingyao Liu

Wenhua Ling

Tianru Jin

2021/3/1

Combined use of GABA and sitagliptin promotes human β-cell proliferation and reduces apoptosis

Journal of Endocrinology

Wenjuan Liu

Harry Kevin Lau

Dong Ok Son

Tianru Jin

Yehong Yang

...

2021/2/1

Hepatic fibroblast growth factor 21 is involved in mediating functions of liraglutide in mice with dietary challenge

Hepatology

Dinghui Liu

Juan Pang

Weijuan Shao

Jianqiu Gu

Yong Zeng

...

2021/10

Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy

Redox biology

Xin Dai

Ruyi Liao

Chaoqun Liu

Si Liu

Haiyan Huang

...

2021/9/1

Estrogen-Wnt signaling cascade regulates expression of hepatic fibroblast growth factor 21

American Journal of Physiology-Endocrinology and Metabolism

Yasaman Badakhshi

Weijuan Shao

Dinghui Liu

Lili Tian

Juan Pang

...

2021/8/1

See List of Professors in Tianru Jin University(University of Toronto)

Co-Authors

H-index: 132
Sylvia L. Asa

Sylvia L. Asa

Case Western Reserve University

H-index: 84
Jonathan Chernoff

Jonathan Chernoff

Temple University

H-index: 74
Patricia Brubaker

Patricia Brubaker

University of Toronto

H-index: 62
Herbert Gaisano

Herbert Gaisano

University of Toronto

H-index: 51
David Irwin

David Irwin

University of Toronto

H-index: 44
Daniel A Winer

Daniel A Winer

University of Toronto

academic-engine